Authors

Alonso La Rosa De Los Rios, Miami Cancer InstituteFollow
Kathryn Mittauer, Miami Cancer InstituteFollow
D Jay Wieczorek, Miami Cancer InstituteFollow
Cecilia Lee, Miami Cancer InstituteFollow
Amy Rzepczynski, Miami Cancer InstituteFollow
Michael Chuong, Miami Cancer InstituteFollow
Tugce Kutuk, Miami Cancer InstituteFollow
Nicole McAllister, Miami Cancer InstituteFollow
Matthew Hall, Miami Cancer InstituteFollow
Alonso Gutierrez, Miami Cancer InstituteFollow
Ranjini Tolakanahalli, Miami Cancer InstituteFollow
Minesh Mehta, Miami Cancer InstituteFollow
Rupesh Kotecha, Miami Cancer InstituteFollow

Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™

Publication Date

9-1-2024

Content Type

Article

PubMed ID:

38431501

Additional Authors:

Additional authors and institutional affiliations

Citation

La Rosa, A., Mittauer, K. E., Bassiri, N., Wieczorek, D. J. J., Lee, Y. C., Rzepczynski, A. E., Chuong, M. D., Kutuk, T., McAllister, N. C., Hall, M. D., Gutierrez, A. N., Tolakanahalli, R., Mehta, M. P., & Kotecha, R. (2024). Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdianⓇ BrainTx™. Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 49(3), 263–270. https://doi.org/10.1016/j.meddos.2024.02.001